Home

Prerequisites

Diagnosis: Establish diagnosis of alcohol withdrawal using DSM-5 criteria. It is crucial to rule out other medical conditions that can mimic withdrawal, such as sepsis, metabolic disturbances, or intracranial events.

BAL (Blood Alcohol Level): While not a contraindication to starting treatment, it is preferable to begin dosing when the BAL is low or falling (e.g., < 0.1 g/dL). This helps differentiate symptoms of intoxication from true withdrawal.

Liver Function: Assess liver function (LFTs, INR, Albumin) to guide benzodiazepine choice. Severe liver impairment may necessitate using a drug with no active metabolites, like Oxazepam.

CIWA-Ar Scale: Commence CIWA-Ar monitoring every 2-4 hours. This objective scale guides symptom-triggered therapy, allowing for tailored dosing and preventing both under- and over-sedation.

Post-withdrawal plan: Ensure there is a follow-up plan in place for ongoing support and monitoring after the withdrawal process. To withdraw without a plan is to risk (1) relapse and broader treatment futility (2) reducing alcohol tolerance and temporarily worsening risks of intoxication.

Thiamine

Prophylaxis (Standard Regimen): To prevent Wernicke's Encephalopathy (WE), all patients undergoing alcohol withdrawal should receive parenteral thiamine. Commence thiamine 300mg IV/IM daily for 3-5 days. Crucially, always administer thiamine BEFORE any glucose-containing fluids.

Suspected Wernicke-Korsakov Syndrome (WKS): Have a high index of suspicion for WKS in any patient with confusion, ataxia, ophthalmoplegia, memory disturbance, or malnutrition. The classic triad is rare. Treatment requires high-dose thiamine: 500mg IV TDS for a minimum of 5 days, followed by oral supplementation.

1. Benzodiazepine Choice

Diazepam: The standard choice due to its long half-life, which provides a smooth, self-tapering effect and reduces the risk of breakthrough symptoms and seizures.

Oxazepam: Preferred in specific situations as it has no active metabolites and is less likely to accumulate.

Use Oxazepam in cases of:
• Significant liver impairment (e.g., cirrhosis, high bilirubin, coagulopathy).
• Respiratory insufficiency or risk of respiratory depression (e.g., COPD).
• Elderly or frail patients who are more sensitive to sedative effects.
• Cerebral trauma / CVA where over-sedation is a risk.

Conversion: Diazepam 10mg is approximately equivalent to Oxazepam 30mg.

Current Selection: Diazepam

2. Regimens (CIWA-Ar)

Displaying Regimens for: Diazepam

Ensure CIWA-Ar done q2hrly at least initially for all patients commenced on regimen. Check BAC before commencing. Do not start CIWA-Ar or benzodiazepines until 6+ hours post last drink. Regularly review patient and adjust as per clinical judgement.

Do not give regular or PRN doses if patient is sedated. If multiple doses are not able to be given, review regular dosing schedule.

Special Cases

Seizures (current or past): Consider loading with benzodiazepines as for severe withdrawal

Alcohol Withdrawal Delirium: Needs ICU/HDU or 1:1 nursing

General Notes: If total daily diazepam equivalent exceeds 80mg, contact specialist service (e.g. D&A CL service, Drug and Alcohol State Advisory Service (DASAS) - 1800 023 687)

Patient Selection Criteria

The following criteria should be met for a patient to be considered for an outpatient (ambulatory) detox.

Inclusion Criteria

  • Age > 18-years-old.
  • Has undertaken a comprehensive AOD assessment.
  • Patient has up-to-date FBC, LFTs, EUCs, INR, and these have been reviewed by the AOD clinician.
  • Patient is diagnosed with an alcohol use disorder.
  • Mild to moderate alcohol withdrawal severity expected, defined by:
    • Average or low risk on Prediction of Alcohol Withdrawal Severity Scale (PAWSS), OR a clear clinical rationale exists for proceeding despite a higher score.
    • Patient’s average alcohol intake is ≤15 standard drinks per day.
  • Patient agrees to daily review at the service.
  • Patient has nominated a pharmacy or other suitable location (e.g. clinic or practice where medicines have been left) for DAILY pickup of medication, and the dispensing location has agreed.
  • Patient has a reasonably safe home environment or supervision.
  • Patient has reliable means for daily reviews (e.g., transport to review or clinician will go to patient).
  • Patient has a reasonable plan for service engagement after detox (e.g., outpatient services, rehabilitation).
  • There is no alcohol remaining in the house prior to detox commencing.

Exclusion Criteria (Contraindications)

  • Medical or psychiatric contraindications, including but not limited to: a seizure disorder, prior or current Wernicke-Korsakoff syndrome, history of suicide attempts, cognitive impairment, or recurrent delirium.
  • Major unmanaged hepatic or renal disease. If present, discussion with an addiction medicine specialist is required regarding regimen modification (e.g., using oxazepam instead of diazepam).
  • Patient is on regular opioids, beta-blockers, or alpha-adrenergic acting agents (e.g., clonidine, prazosin) due to potential interactions and/or masking of alcohol withdrawal symptoms.

Example Daily Protocol

This is an example process for a structured outpatient detox program.

  • All detoxes start on Monday, cease on Friday, and are organised the week prior.
  • Scripts for the weaning regimen are written by the patient's GP or a service medical officer.
  • Patient must present daily for review:
    • Nursing staff perform a CIWA-Ar assessment in the AM before the first dose of the day.
    • Nursing staff perform a brief delirium screen daily (e.g., 4AT screen).
    • Nursing staff perform a breathalyser test. All patients must have an undetectable BAL to qualify for further benzodiazepines.
    • Basic observations are taken (HR, BP, RR, temperature).
    • If all checks are satisfactory, staff will call the nominated pharmacy to authorise the dispensing of the next day's supply of medication.
  • Medical Officer Review Triggers:
    • Nursing staff should call the AOD medical officer if CIWA-Ar score is >20 or other complications arise.
    • The medical officer should consider calling a specialist service (e.g., DASAS 1800 023 687) if withdrawal appears severe despite treatment.
    • Top-up doses may be considered in rare circumstances via a separate, specific script.

Medication Regimen

Example Diazepam Regimen (Fixed-Dose):

A common approach is a 5-day fixed-dose weaning regimen. This must be adjusted based on clinical assessment. Staged, daily supply from a pharmacy is essential.

  • Day 1: 10mg QID (four times a day)
  • Day 2: 10mg TDS (three times a day)
  • Day 3: 10mg BD (twice a day)
  • Day 4: 5mg BD (twice a day)
  • Day 5: 5mg Nocte (at night), then cease.

Dosing Times:

A QID (four times a day) schedule can be challenging. While ideal times might be 0600, 1200, 1800, 2200, a more realistic schedule based on service opening hours might be:

09:00, 13:00, 18:00, 22:00

It is helpful to provide the patient with a pictorial or clearly written schedule of their dosing times.

When to Cease or Escalate Care

Situations Triggering Protocol to be Aborted

  • Patient has a positive BAL (Blood Alcohol Level).
  • Patient does not present for reviews or is not taking diazepam as directed (e.g., taking takeaway doses all at once).
  • Use of other interacting substances (e.g., opioids, illicit drugs).
  • Verbal abuse or violence towards staff.
  • Oversedation despite the clinician decreasing doses.

Situations Triggering Presentation to Hospital

  • Seizures
  • Delirium
  • Hallucinations
  • Suicidality
  • Other acute medical concerns
Beer
Wine & Champagne
Casks & Fortified Wine
Spirits & Pre-mix (RTDs)

Calculate by Volume and ABV

Alcohol Withdrawal Scale (AWS)

Perspiration
Tremor
Anxiety
Agitation
Axilla temperature
Hallucinations (sight, sound, taste or touch)
Orientation
0 Mild withdrawal

CIWA-Ar

Nausea and vomiting
Tremor
Paroxysmal sweats
Anxiety
Agitation
Tactile disturbances
Auditory disturbances
Visual disturbances
Headaches, fullness in head
Orientation and clouding of sensorium
0 Mild withdrawal

SAWS (Short Alcohol Withdrawal Scale)

Anxious
Sleep disturbance
Memory problems
Nausea
Restless
Tremor (shakes)
Feeling confused
Sweating
Miserable
Heart pounding
0 None

COWS (Clinical Opiate Withdrawal Scale)

Resting Pulse Rate
Sweating
Restlessness
Pupil size
Bone or joint aches
Runny nose or tearing
GI Upset
Tremor
Yawning
Anxiety or irritability
Gooseflesh skin
0 Minimal Withdrawal

CIWA-B (Benzodiazepine)

1. Nausea and Vomiting
2. Tremor
3. Diaphoresis (Sweating)
4. Anxiety
5. Agitation
6. Tactile Disturbances
7. Auditory Disturbances
8. Visual Disturbances
9. Headache
10. Clouding of Sensorium (Orientation)
0 Mild withdrawal

Cannabis Withdrawal Scale

Note: This is a monitoring tool, not a diagnostic one. Higher scores indicate greater severity.

1. Craving for marijuana
2. Decreased appetite
3. Sleep difficulty
4. Increased aggression
5. Increased anger
6. Increased irritability
7. Increased nervousness
8. Restlessness
9. Strange/vivid dreams
10. Nausea
11. Stomach ache
12. Shakiness/tremors
13. Sweating
14. Headache
15. Depressed mood
16. Chills
17. Physical tension
18. Yawning
19. Runny nose
0 N/A

Cannabis Withdrawal Assessment Scale (CWAS)

Note: This is a monitoring tool. Higher scores indicate greater severity.

1. Craving for marijuana
2. Decreased appetite
3. Sleep difficulty
4. Increased aggression
5. Increased anger
6. Irritability
7. Strange dreams
8. Restlessness
9. Chills
10. Feverish feeling
11. Stuffy nose
12. Nausea
13. Diarrhoea
14. Hot flashes
15. Dizziness
16. Sweating
17. Hiccups
18. Yawning
19. Headaches
20. Shakiness
21. Muscle spasms
22. Stomach pains
23. Fatigue
24. Depressed mood
25. Difficulty concentrating
26. Nervousness
27. Violent outbursts
0 N/A